The advanced autoantibody panel, Neural Zoomer Plus , screens for immune reactivity to key neural targets, including myelin basic protein, NMDA receptors, gangliosides, synapsin, S100B, and blood-brain barrier proteins
CJC-1295 and Ipamorelin increase GH output and IGF-1 levels, while BPC-157 accelerates structural healing
Fill out a brief medical intake form
In Russia, Semax has been: Approved as a pharmaceutical since 2011 Prescribed for ischemic stroke (acute and recovery phases) Used for cognitive disorders, including memory impairment and attention deficits Administered as a nasal spray, making it convenient and non-invasive Studied extensively, with hundreds of published scientific papers Given to healthy individuals for cognitive optimization (a practice common among Russian military and high-performance professionals) This decades-long track record of clinical use with a robust safety profile documented in Russian medical literature is one of the strongest arguments for Semax's inclusion on the US 503A compounding list
Researchers studying obesity and metabolic syndrome research frequently use this peptide as a reference compound or experimental tool
